Theodore W Laetsch Selected Research

Genetic Translocation (Chromosomal Translocation)

1/2022	NTRK-fusions in pediatric thyroid tumors: Current state and future perspectives.
1/2022	The clinical aspect of NTRK-fusions in pediatric papillary thyroid cancer.
1/2019	TRK Fusion Cancers in Children: A Clinical Review and Recommendations for Screening.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Theodore W Laetsch Research Topics

Disease

41	Neoplasms (Cancer) 05/2024 - 09/2016
29	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2023 - 01/2018
6	Cytokine Release Syndrome 01/2023 - 01/2018
6	Neuroblastoma 01/2023 - 09/2016
4	Sarcoma (Soft Tissue Sarcoma) 11/2018 - 10/2016
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2022
3	Genetic Translocation (Chromosomal Translocation) 01/2022 - 01/2019
3	Hyperthermia 01/2020 - 01/2016
2	Leukemia 10/2022 - 01/2022
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2022 - 01/2018
2	Central Nervous System Neoplasms 01/2022 - 01/2021
2	Infections 01/2021 - 01/2021
2	Rhabdomyosarcoma 01/2021 - 01/2018
2	Nausea 01/2020 - 01/2018
2	Microsatellite Instability 01/2020 - 11/2017
2	Fibrosarcoma 01/2020 - 01/2018
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2023
1	Osteosarcoma (Osteogenic Sarcoma) 01/2023
1	Hyperferritinemia 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 12/2022
1	Hypokalemia 10/2022
1	Febrile Neutropenia 10/2022
1	Tumor Lysis Syndrome 10/2022
1	Mucositis 10/2022
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2022
1	Adenocarcinoma 01/2022
1	Alveolar Rhabdomyosarcoma 01/2022
1	Residual Neoplasm 01/2022
1	Medulloblastoma 01/2022
1	Acinar Cell Carcinoma 01/2022
1	Down Syndrome (Down's Syndrome) 01/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2021
1	Hemorrhage 01/2021
1	Pinealoma (Pineoblastoma) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Neurofibrosarcoma (MPNST) 12/2020

Drug/Important Bio-Agent (IBA)

20	tisagenlecleucelIBA 11/2023 - 01/2018
17	Chimeric Antigen ReceptorsIBA 10/2023 - 01/2018
15	larotrectinibIBA 05/2024 - 01/2018
10	Phosphotransferases (Kinase)IBA 12/2022 - 01/2018
8	TropomyosinIBA 12/2022 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 10/2019
3	Alanine Transaminase (SGPT)IBA 10/2022 - 01/2020
2	CD19 AntigensIBA 10/2023 - 01/2022
2	Liposomes (Liposome)IBA 01/2023 - 01/2020
2	liposomal doxorubicin (Doxil)FDA Link 01/2023 - 01/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2022 - 10/2022
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2020
2	entrectinibIBA 01/2022 - 01/2021
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 01/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020 - 01/2018
2	tocilizumab (atlizumab)FDA Link 01/2019 - 01/2018
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023
1	fludarabineIBA 12/2022
1	temsirolimus FDA Link 10/2022
1	TOR Serine-Threonine KinasesIBA 10/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2022
1	Etoposide (VP 16)FDA LinkGeneric 10/2022
1	CrizotinibIBA 09/2022
1	3-amino-1-methyl-3-(4-(3-phenyl-5H- imidazo(1,2- c)pyrido(3,4- e)(1,3)oxazin- 2- yl)phenyl)cyclobutanolIBA 09/2022
1	Tyrosine Kinase InhibitorsIBA 09/2022
1	Tuberculin (PPD)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Neuropilin-1IBA 01/2022
1	TB-403IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	CD19-specific chimeric antigen receptorIBA 01/2022
1	blinatumomabIBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 12/2021
1	olaratumabIBA 01/2021
1	crisamicin AIBA 01/2021
1	navitoclaxIBA 01/2021
1	venetoclaxIBA 01/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021
1	Fibrinogen (Factor I)FDA Link 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	NucleotidesIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	TransferasesIBA 01/2021
1	Vincristine (Oncovin)FDA LinkGeneric 01/2021
1	AZD 6244IBA 12/2020
1	trametinibIBA 12/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2020

Therapy/Procedure

24	Therapeutics 05/2024 - 09/2016
11	Drug Therapy (Chemotherapy) 01/2023 - 09/2016
6	Immunotherapy 11/2023 - 01/2019
2	Investigational Therapies (Experimental Therapy) 10/2023 - 05/2020
2	Microbubbles 01/2023 - 01/2020
2	Transplantation 11/2019 - 01/2019
2	Extracorporeal Shockwave Therapy 10/2016 - 01/2016
1	Hematopoietic Stem Cell Transplantation 10/2023
1	Stem Cell Transplantation 01/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021